Second fiscal quarter revenue of $833 million, within the $820-$850 million guidance range. Foreign currency movements negatively affected revenue by approximately $2 million relative to the first quarter of fiscal 2013

Second fiscal quarter non-GAAP operating income of $140 million; non-GAAP operating margin of 16.8%; GAAP operating income of $123 million

Diluted GAAP EPS of $0.64 for the second fiscal quarter, compared to the $0.58-$0.66 guidance range

Free cash flow of $91 million for the second fiscal quarter

Twelve-month backlog of $2.81 billion at the end of the second fiscal quarter, up $10 million from the end of the first quarter of fiscal 2013

Repurchased $109 million of ordinary shares during the second fiscal quarter

The board of directors approved a $0.13 per share quarterly cash dividend to be paid on July 19, 2013

Third quarter fiscal 2013 guidance: Expected revenue of approximately $825-$855 million and diluted non-GAAP EPS of $0.70-$0.76, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Diluted GAAP EPS is expected to be approximately $0.60-$0.68

Amdocs Limited (NYSE: DOX) today reported that for its fiscal quarter ended March 31, 2013, revenue was $832.9 million, up 0.8% sequentially from the first fiscal quarter of 2013 and up 3.0% as compared to last year's second fiscal quarter. Net income on a non-GAAP basis was $119.3 million, or $0.73 per diluted share, compared to non-GAAP net income of $114.7 million, or $0.67 per diluted share, in the second quarter of fiscal 2012. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expenses of $14.4 million, net of related tax effects, in the second quarter of fiscal 2013 and excludes such amortization and other acquisition related costs, gain on sale of investment and equity-based compensation expenses of $12.8 million, net of related tax effects, in the second quarter of fiscal 2012. The Company's GAAP net income for the second quarter of fiscal 2013 was $104.9 million, or $0.64 per diluted share, compared to GAAP net income of $101.9 million, or $0.60 per diluted share, in the prior fiscal year's second quarter.

"We followed-up our strong start to fiscal 2013 by delivering record revenues in the second fiscal quarter. We achieved year-on-year improvement in North America for the second consecutive quarter, driven by AT&T and other key customers. This compensated for currency headwinds, the effects of macroeconomic uncertainty, and longer decision making cycles in Europe. Operating margin remained comfortably within our targeted range, and, with the contribution from our continued share repurchase activity, we delivered non-GAAP earnings per share growth of 9% year-on-year in the second fiscal quarter," said Eli Gelman, chief executive officer of Amdocs Management Limited.

Gelman continued, "During the quarter, we continued to sign new business and achieve key milestones with new and existing customers. For example, we have achieved the first of several important delivery milestones under the pivotal managed transformation with Globe Telecom. Additionally, in the second fiscal quarter we reached key production milestones in the modernization of both US Cellular and Vodafone Netherland's Business Support Systems. In Broadband, Cable & Satellite, Amdocs has expanded its Comcast relationship to provide managed services for Comcast's Operational Support Systems, in addition to its billing systems."

Gelman concluded, "Our free cash flow continues to be strong and we remain focused on efficiently allocating our cash over the long-term. Looking toward the second half of fiscal 2013, we will continue to monitor macroeconomic and industry conditions closely, which include the uncertainty arising from announced M&A activity among operators in North America and macroeconomic pressures, especially in Europe. Based on our current market outlook, we believe that we can perform within the fiscal year 2013 guidance ranges furnished at the beginning of the year and provide an attractive total return to our shareholders."

Financial Discussion of Second Fiscal Quarter Results Free cash flow was $91 million for the quarter, comprised of cash flow from operations of $120 million less $29 million in net capital expenditures and other.

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $2.81 billion at the end of the second quarter of fiscal 2013.

Financial OutlookAmdocs expects that revenue for the third quarter of fiscal 2013 will be approximately $825-$855 million. Diluted earnings per share on a non-GAAP basis for the third fiscal quarter are expected to be $0.70-$0.76, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Amdocs estimates GAAP diluted earnings per share for the third fiscal quarter will be $0.60-$0.68.

Quarterly Cash Dividend Program On April 30, 2013, the Board approved the Company's next quarterly cash dividend payment and set June 28, 2013 as the record date for determining the shareholders entitled to receive the dividend, which is payable on July 19, 2013.

Conference Call Details Amdocs will host a conference call on April 30, 2013 at 5:00 p.m. Eastern Time to discuss the Company's second fiscal quarter results. The call will be carried live on the Internet via the Amdocs website, www.amdocs.com.

amortization of purchased intangible assets and other acquisition related costs;

gain on sale of investment;

equity-based compensation expense; and

tax effects related to the above.

These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs' results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs' results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other (expense) income, net, non-GAAP income taxes and non-GAAP net income when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs' management uses financial statements that do not include amortization of purchased intangible assets and other acquisition related costs, gain on sale of investment, equity-based compensation expense and related tax effects. Amdocs' management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of service, research and development, selling, general and administrative, operating income, interest and other (expense) income, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

About AmdocsFor 30 years, Amdocs has ensured service providers' success and embraced their biggest challenges. To win in the connected world, service providers rely on Amdocs to simplify the customer experience, harness the data explosion, stay ahead with new services and improve operational efficiency. The global company uniquely combines a market-leading BSS, OSS and network control product portfolio with value-driven professional services and managed services operations. With revenue of $3.2 billion in fiscal 2012, Amdocs and its approximately 20,000 employees serve customers in more than 60 countries.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company's filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2012 filed on December 11, 2012 and our Form 6-K furnished for the first quarter of fiscal 2013 on February 12, 2013.

AMDOCS LIMITED

Consolidated Statements of Income (in thousands, except per share data)

Three months ended

Six months ended

March 31,

March 31,

2013

2012

2013

2012

Revenue:

License

$ 21,901

$ 26,238

$ 40,817

$ 62,034

Service

811,037

782,690

1,618,480

1,553,904

832,938

808,928

1,659,297

1,615,938

Operating expenses:

Cost of license

642

995

1,278

1,926

Cost of service

538,094

517,549

1,073,107

1,033,730

Research and development

60,059

60,350

119,419

121,657

Selling, general and administrative

102,683

106,842

210,143

213,179

Amortization of purchased intangible assets and other

8,605

13,320

19,838

26,526

710,083

699,056

1,423,785

1,397,018

Operating income

122,855

109,872

235,512

218,920

Interest and other (expense) income, net

(1,757)

5,286

(1,865)

1,673

Income before income taxes

121,098

115,158

233,647

220,593

Income taxes

16,186

13,288

29,720

25,992

Net income

$ 104,912

$ 101,870

$ 203,927

$ 194,601

Basic earnings per share

$ 0.65

$ 0.60

$ 1.26

$ 1.14

Diluted earnings per share

$ 0.64

$ 0.60

$ 1.25

$ 1.13

Basic weighted average number of shares outstanding

160,955

169,739

161,569

171,231

Diluted weighted average number of shares outstanding

162,884

170,971

163,239

172,397

Cash dividends declared per share

$ 0.13

$ -

$ 0.26

$ -

AMDOCS LIMITED

Selected Financial Metrics

(in thousands, except per share data)

Three months ended

Six months ended

March 31,

March 31,

2013

2012

2013

2012

Revenue

$ 832,938

$ 808,928

$ 1,659,297

$ 1,615,938

Non-GAAP operating income

140,169

134,312

277,384

267,119

Non-GAAP net income

119,300

114,703

238,724

225,957

Non-GAAP diluted earnings per share

$ 0.73

$ 0.67

$ 1.46

$ 1.31

Diluted weighted average number of shares outstanding

162,884

170,971

163,239

172,397

AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)

Three months ended

March 31, 2013

Reconciliation items

GAAP

Amortization of purchased intangible assets and other

Equity based compensation expense

Tax effect

Non-GAAP

Operating expenses:

Cost of license

$ 642

$ -

$ -

$ -

$ 642

Cost of service

538,094

-

(4,470)

-

533,624

Research and development

60,059

-

(975)

-

59,084

Selling, general and administrative

102,683

-

(3,264)

-

99,419

Amortization of purchased intangible assets and other

8,605

(8,605)

-

-

-

Total operating expenses

710,083

(8,605)

(8,709)

-

692,769

Operating income

122,855

8,605

8,709

-

140,169

Income taxes

16,186

-

-

2,926

19,112

Net income

$ 104,912

$ 8,605

$ 8,709

$ (2,926)

$ 119,300

Three months ended

March 31, 2012

Reconciliation items

GAAP

Amortization of purchased intangible assets and other

Equity based compensation expense

Gain on sale of investment

Tax effect

Non-GAAP

Operating expenses:

Cost of license

$ 995

$ -

$ -

$ -

$ -

$ 995

Cost of service

517,549

-

(5,763)

-

-

511,786

Research and development

60,350

-

(1,172)

-

-

59,178

Selling, general and administrative

106,842

-

(4,185)

-

-

102,657

Amortization of purchased intangible assets and other

13,320

(13,320)

-

-

-

-

Total operating expenses

699,056

(13,320)

(11,120)

-

-

674,616

Operating income

109,872

13,320

11,120

-

-

134,312

Interest and other (expense) income, net

5,286

-

-

(6,270)

-

(984)

Income taxes

13,288

-

-

-

5,337

18,625

Net income

$ 101,870

$ 13,320

$ 11,120

$ (6,270)

$ (5,337)

$ 114,703

AMDOCS LIMITEDReconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)

Six months ended

March 31, 2013

Reconciliation items

GAAP

Amortization of purchased intangible assets and other

Equity based compensation expense

Tax effect

Non-GAAP

Operating expenses:

Cost of license

$ 1,278

$ -

$ -

$ -

$ 1,278

Cost of service

1,073,107

-

(9,503)

-

1,063,604

Research and development

119,419

-

(2,000)

-

117,419

Selling, general and administrative

210,143

-

(10,531)

-

199,612

Amortization of purchased intangible assets and other

19,838

(19,838)

-

-

-

Total operating expenses

1,423,785

(19,838)

(22,034)

-

1,381,913

Operating income

235,512

19,838

22,034

-

277,384

Income taxes

29,720

-

-

7,075

36,795

Net income

$ 203,927

$ 19,838

$ 22,034

$ (7,075)

$ 238,724

Six months ended

March 31, 2012

Reconciliation items

GAAP

Amortization of purchased intangible assets and other

Equity based compensation expense

Gain on sale of investment

Tax effect

Non-GAAP

Operating expenses:

Cost of license

$ 1,926

$ -

$ -

$ -

$ -

$ 1,926

Cost of service

1,033,730

-

(11,366)

-

-

1,022,364

Research and development

121,657

-

(2,213)

-

-

119,444

Selling, general and administrative

213,179

-

(8,094)

-

-

205,085

Amortization of purchased intangible assets and other

26,526

(26,526)

-

-

-

-

Total operating expenses

1,397,018

(26,526)

(21,673)

-

-

1,348,819

Operating income

218,920

26,526

21,673

-

-

267,119

Interest and other (expense) income, net

1,673

-

-

(6,270)

-

(4,597)

Income taxes

25,992

-

-

-

10,573

36,565

Net income

$ 194,601

$ 26,526

$ 21,673

$ (6,270)

$ (10,573)

$ 225,957

AMDOCS LIMITED Condensed Consolidated Balance Sheets (in thousands)

As of

March 31,2013

September 30,2012

ASSETS

Current assets

Cash, cash equivalents and short-term interest-bearing investments

$ 978,157

$ 1,118,177

Accounts receivable, net, including unbilled of $124,415 and $130,697, respectively

669,531

687,223

Deferred income taxes and taxes receivable

123,428

109,282

Prepaid expenses and other current assets

166,347

126,388

Total current assets

1,937,463

2,041,070

Equipment and leasehold improvements, net

268,962

277,907

Goodwill and other intangible assets, net

1,862,805

1,883,064

Other noncurrent assets

424,447

443,182

Total assets

$ 4,493,677

$ 4,645,223

LIABILITIES AND SHAREHOLDERS' EQUITY

Current Liabilities

Accounts payable, accruals and other

$ 587,551

$ 690,823

Short-term financing arrangements

-

200,000

Deferred revenue

160,681

145,184

Deferred income taxes and taxes payable

33,126

29,551

Total current liabilities

781,358

1,065,558

Other noncurrent liabilities

562,747

546,463

Shareholders' equity

3,149,572

3,033,202

Total liabilities and shareholders' equity

$ 4,493,677

$ 4,645,223

AMDOCS LIMITED

Consolidated Statements of Cash Flows

(in thousands)

Six months ended March 31,

2013

2012

Cash Flow from Operating Activities:

Net income

$ 203,927

$ 194,601

Reconciliation of net income to net cash provided by operating activities: